Tissue distribution of glutamate carboxypeptidase II (GCPII) with a focus on the central and peripheral nervous system

Current Medicinal Chemistry

Volumn 19, Issue 9, 2012, Pages 1277-1281

  Marmiroli, P ^a   Slusher, B ^b   Cavaletti, G ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; glutamate; glutamate carboxypeptidase II; N acetylaspartylglutamate (NAAG); peripheral nervous system

Indexed keywords

GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PROTEIN LOCALIZATION; REVIEW; SYNAPSE; WESTERN BLOTTING;

ANIMALS; CENTRAL NERVOUS SYSTEM; DIPEPTIDES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; PERIPHERAL NERVOUS SYSTEM;

EID: 84858110856     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799462568     Document Type: Review

References (46)

1. Curatolo, A.; D'Arcangelo, P.; Lino, A.; Brancati, A. Distribution of N-Acetyl-Aspartic and N-Acetyl-Aspartyl-Glutamic Acids in Nervous Tissue. J. Neurochem. 1965,12, 339-42.
2. Neale, J.H.; Bzdega, T.; Wroblewska, B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 2000,75, 443-52. (Pubitemid 30485424)
3. Thomas, A.G.; Wozniak, K.M.; Tsukamoto, T.; Calvin, D.; Wu, Y.; Rojas, C.; Vornov, J.; Slusher, B.S. Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy. Adv. Exp. Med. Biol. 2006,576, 327-37; discussion 361-3.
4. Coyle, J.T. The nagging question of the function of N- acetylaspartylglutamate. Neurobiol. Dis. 1997,4, 231-8. (Pubitemid 27465513)
5. Valivullah, H.M.; Lancaster, J.; Sweetnam, P.M.; Neale, J.H. Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites. J. Neurochem. 1994,63, 1714-9.
6. Wroblewska, B.; Wroblewski, J.T.; Pshenichkin, S.; Surin, A.; Sullivan, S.E.; Neale, J.H. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 1997,69, 174-81. (Pubitemid 27274170)
7. Tsai, G.; Forloni, G.; Robinson, M.B.; Stauch, B.L.; Coyle, J.T. Calcium-dependent evoked release of N-[3H]acetylaspartylglutamate from the optic pathway. J. Neurochem. 1988,51, 1956-9. (Pubitemid 19010992)
8. Barinka, C.; Rinnova, M.; Sacha, P.; Rojas, C.; Majer, P.; Slusher, B.S.; Konvalinka, J. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J. Neurochem. 2002,80, 477-87. (Pubitemid 36383031)
9. Barinka, C.; Sacha, P.; Sklenar, J.; Man, P.; Bezouska, K.; Slusher, B.S.; Konvalinka, J. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein. Sci. 2004,13, 1627-35. (Pubitemid 38669250)
10. Davis, M.I.; Bennett, M.J.; Thomas, L.M.; Bjorkman, P.J. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc. Natl. Acad. Sci U S A 2005,102, 5981-6. (Pubitemid 40594241)
11. Mesters, J.R.; Barinka, C.; Li, W.; Tsukamoto, T.; Majer, P.; Slusher, B.S.; Konvalinka, J.; Hilgenfeld, R. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. Embo. J. 2006,25, 1375-84.
12. Halsted, C.H.; Ling, E.H.; Luthi-Carter, R.; Villanueva, J.A.; Gardner, J.M.; Coyle, J.T. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J. Biol. Chem. 1998,273, 20417-24. (Pubitemid 28377608)
13. Carter, R.E.; Feldman, A.R.; Coyle, J.T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. U S A 1996,93, 749-53. (Pubitemid 26041162)
14. Su, S.L.; Huang, I.P.; Fair, W.R.; Powell, C.T.; Heston, W.D. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer. Res. 1995,55, 1441-3.
15. Slusher, B.S.; Tsai, G.; Yoo, G.; Coyle, J.T. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Comp. Neurol. 1992,315, 217-29.
16. Robinson, M.B.; Blakely, R.D.; Couto, R.; Coyle, J.T. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J. Biol. Chem. 1987,262, 14498-506. (Pubitemid 17157357)
17. Pangalos, M.N.; Neefs, J.M.; Somers, M.; Verhasselt, P.; Bekkers, M.; van der Helm, L.; Fraiponts, E.; Ashton, D.; Gordon, R.D. Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity. J. Biol. Chem. 1999,274, 8470-83. (Pubitemid 29164636)
18. Hlouchova, K.; Barinka, C.; Konvalinka, J.; Lubkowski, J. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III. FEBS J. 2009, 276, 4448-62
19. Bzdega, T.; Crowe, S.L.; Ramadan, E.R.; Sciarretta, K.H.; Olszewski, R.T.; Ojeifo, O.A.; Rafalski, V.A.; Wroblewska, B.; Neale, J.H. The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J. Neurochem. 2004,89, 627-35.
20. Bacich, D.J.; Ramadan, E.; O'Keefe, D.S.; Bukhari, N.; Wegorzewska, I.; Ojeifo, O.; Olszewski, R.; Wrenn, C.C.; Bzdega, T.; Wroblewska, B.; Heston, W.D.; Neale, J.H. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J. Neurochem. 2002,83, 20-9.
21. O'Keefe, D.S.; Bacich, D.J.; Heston, W.D. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 2004,58, 200-10. (Pubitemid 38160908)
22. Rajasekaran, S.A.; Christiansen, J.J.; Schmid, I.; Oshima, E.; Ryazantsev, S.; Sakamoto, K.; Weinstein, J.; Rao, N.P.; Rajasekaran, A.K. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Mol. Cancer. Ther. 2008,7, 2142-51.
23. Conway, R.E.; Petrovic, N.; Li, Z.; Heston, W.; Wu, D.; Shapiro, L.H. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol. Cell. Biol. 2006,26, 5310-24. (Pubitemid 44036201)
24. Slusher, B.S.; Vornov, J.J.; Thomas, A.G.; Hurn, P.D.; Harukuni, I.; Bhardwaj, A.; Traystman, R.J.; Robinson, M.B.; Britton, P.; Lu, X.C.; Tortella, F.C.; Wozniak, K.M.; Yudkoff, M.; Potter, B.M.; Jackson, P.F. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 1999,5, 1396-402.
25. Lu, X.M.; Tang, Z.; Liu, W.; Lin, Q.; Slusher, B.S. N- acetylaspartylglutamate protects against transient focal cerebral ischemia in rats. Eur. J. Pharmacol. 2000,408, 233-9.
26. Jackson, P.F.; Tays, K.L.; Maclin, K.M.; Ko, Y.S.; Li, W.; Vitharana, D.; Tsukamoto, T.; Stoermer, D.; Lu, X.C.; Wozniak, K.; Slusher, B.S. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. J. Med. Chem. 2001,44, 4170-5. (Pubitemid 33095323)
27. Yamamoto, T.; Hirasawa, S.; Wroblewska, B.; Grajkowska, E.; Zhou, J.; Kozikowski, A.; Wroblewski, J.; Neale, J.H. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur. J. Neurosci. 2004,20, 483-94. (Pubitemid 38969633)
28. Zhang, W.; Slusher, B.; Murakawa, Y.; Wozniak, K.M.; Tsukamoto, T.; Jackson, P.F.; Sima, A.A. GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats. J. Neurol. Sci. 2002,194, 21-8. (Pubitemid 34051551)
29. Carozzi, V.A.; Chiorazzi, A.; Canta, A.; Lapidus, R.G.; Slusher, B.S.; Wozniak, K.M.; Cavaletti, G. Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat. Neurotox. Res. 2010,17, 380-91.
30. Neale, J.H.; Olszewski, R.T.; Gehl, L.M.; Wroblewska, B.; Bzdega, T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends. Pharmacol. Sci. 2005,26, 477-84. (Pubitemid 41207880)
31. Ghadge, G.D.; Slusher, B.S.; Bodner, A.; Canto, M.D.; Wozniak, K.; Thomas, A.G.; Rojas, C.; Tsukamoto, T.; Majer, P.; Miller, R.J.; Monti, A.L.; Roos, R.P. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc. Natl. Acad. Sci. U S A 2003,100, 9554-9. (Pubitemid 37033966)
32. Fuhrman, S.; Palkovits, M.; Cassidy, M.; Neale, J.H. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system. J. Neurochem. 1994,62, 275-81.
33. Berger, U.V.; Luthi-Carter, R.; Passani, L.A.; Elkabes, S.; Black, I.; Konradi, C.; Coyle, J.T. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 1999,415, 52-64. (Pubitemid 29519885)
34. Berger, U.V.; Carter, R.E.; McKee, M.; Coyle, J.T. N-acetylated alpha-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system. J. Neurocytol. 1995,24, 99-109.
35. Berger, U.V.; Carter, R.E.; Coyle, J.T. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience 1995,64, 847-50.
36. Sacha, P.; Zamecnik, J.; Barinka, C.; Hlouchova, K.; Vicha, A.; Mlcochova, P.; Hilgert, I.; Eckschlager, T.; Konvalinka, J. Expression of glutamate carboxypeptidase II in human brain. Neuroscience 2007,144, 1361-72. (Pubitemid 46123795)
37. Horoszewicz, J.S.; Kawinski, E.; Murphy, G.P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer. Res. 1987,7, 927-35. (Pubitemid 18036141)
38. Lopes, A.D.; Davis, W.L.; Rosenstraus, M.J.; Uveges, A.J.; Gilman, S.C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res. 1990,50, 6423-9. (Pubitemid 20323709)
39. Silver, D.A.; Pellicer, I.; Fair, W.R.; Heston, W.D.; Cordon-Cardo, C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 1997,3, 81-5. (Pubitemid 27079448)
40. Chang, S.S.; Reuter, V.E.; Heston, W.D.; Bander, N.H.; Grauer, L.S.; Gaudin, P.B. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999,59, 3192-8. (Pubitemid 29316022)
41. Troyer, J.K.; Beckett, M.L.; Wright, G.L. Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer 1995,62, 552-8.
42. Israeli, R.S.; Powell, C.T.; Corr, J.G.; Fair, W.R.; Heston, W.D. Expression of the prostate-specific membrane antigen. Cancer Res. 1994,54, 1807-11. (Pubitemid 24116191)
43. Luthi-Carter, R.; Barczak, A.K.; Speno, H.; Coyle, J.T. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Pharmacol. Exp. Ther. 1998,286, 1020-5. (Pubitemid 29003499)
44. Renneberg, H.; Friedetzky, A.; Konrad, L.; Kurek, R.; Weingartner, K.; Wennemuth, G.; Tunn, U.W.; Aumuller, G. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread. Urol. Res. 1999,27, 23-7. (Pubitemid 29145087)
45. Huang, X.; Bennett, M.; Thorpe, P.E. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Prostate 2004,61, 1-11. (Pubitemid 39095691)
46. Rojas, C.; Stathis, M.; Polydefkis, M.; Rudek, M.A.; Zhao, M.; Ebenezer, G.J.; Slusher, B.S. Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies. J. Transl. Med. 2011,9, 27.